Classic Congenital Adrenal Hyperplasia (CAH): Pathophysiology & Management

Classic CAH is an autosomal recessive disorder (21-hydroxylase deficiency, CYP21A2) causing cortisol and aldosterone deficiency with androgen excess. Incidence ~1:15,000.

Pathophysiology

  • 21-OH block → 17-OHP accumulates → shunted to androgens (androstenedione, testosterone).
  • Cortisol deficiency → loss of negative feedback → ACTH ↑ → adrenal hyperplasia.
  • Aldosterone deficiency → salt-wasting (75% of classic) → hyponatremia, hyperkalemia, volume depletion.

Presentation

  • 46,XX: Ambiguous genitalia at birth (Prader III–V); postnatal virilization.
  • 46,XY: Normal genitalia; may present with salt-wasting crisis (7–14 days) or precocious puberty.

Complications

  • Growth acceleration → advanced bone age → short adult stature.
  • Adrenal crises (infection, stress, trauma).
  • Testicular adrenal rest tumors (males).
  • Fertility challenges, PCOS features (females).
  • Psychosexual adjustment.

Management

  • Glucocorticoid replacement: Hydrocortisone (10–15 mg/m²/day divided TID); stress dosing.
  • Mineralocorticoid: Fludrocortisone 0.05–0.2 mg/day + salt supplementation (infants).
  • Monitoring: 17-OHP, androstenedione, renin, electrolytes, growth, bone age.
  • Prenatal dexamethasone (controversial) reduces virilization in 46,XX fetuses.

Newborn screening enables early treatment. Multidisciplinary care (endocrine, urology, genetics, psychology) optimizes lifelong outcomes.

Genetic Disorders - Related Articles